Genmab Publishes 2024 Annual Report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Reddit leads social media platforms in revenue growth per user
- L3Harris CEO steps down amid conduct review, shares drop
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
- US considers new sanctions on Brazilian judge, FT reports
- Six dead in 'stampede-like' incident at India temple, ANI says
Truist Securities Reiterates Buy Rating on Genmab A/S (GMAB)
February 13, 2025 7:17 AM ESTTruist Securities analyst Asthika Goonewardene reiterated a Buy rating and $50.00 price target on Genmab A/S (NASDAQ: GMAB).
The analyst comments "We believe investors are anxious to own GMAB ahead of J&J's (JNJ, Not Rated) decision to opt-in on GEN3014, and... More
